As of 2024-07-27, the Relative Valuation of Cara Therapeutics Inc (CARA) is (35.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.37 USD, the upside of Cara Therapeutics Inc based on Relative Valuation is -9607.6%.
The range of the Relative Valuation is (37.42) - (22.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 10.1x - 10.2x | 10.1x |
Forward P/E multiples | 16.7x - 26.2x | 21.4x |
Fair Price | (37.42) - (22.86) | (35.41) |
Upside | -10149.2% - -6237.8% | -9607.6% |
Date | P/E |
2024-07-26 | -0.17 |
2024-07-25 | -0.16 |
2024-07-24 | -0.16 |
2024-07-23 | -0.17 |
2024-07-22 | -0.16 |
2024-07-19 | -0.15 |
2024-07-18 | -0.15 |
2024-07-17 | -0.15 |
2024-07-16 | -0.17 |
2024-07-15 | -0.15 |
2024-07-12 | -0.16 |
2024-07-11 | -0.16 |
2024-07-10 | -0.13 |
2024-07-09 | -0.13 |
2024-07-08 | -0.13 |
2024-07-05 | -0.13 |
2024-07-03 | -0.12 |
2024-07-02 | -0.12 |
2024-07-01 | -0.12 |
2024-06-28 | -0.12 |
2024-06-27 | -0.14 |
2024-06-26 | -0.13 |
2024-06-25 | -0.15 |
2024-06-24 | -0.15 |
2024-06-21 | -0.12 |
2024-06-20 | -0.11 |
2024-06-18 | -0.11 |
2024-06-17 | -0.11 |
2024-06-14 | -0.16 |
2024-06-13 | -0.20 |
2024-06-12 | -0.30 |
2024-06-11 | -0.30 |
2024-06-10 | -0.30 |
2024-06-07 | -0.28 |
2024-06-06 | -0.29 |
2024-06-05 | -0.31 |
2024-06-04 | -0.30 |
2024-06-03 | -0.30 |
2024-05-31 | -0.29 |
2024-05-30 | -0.27 |
2024-05-29 | -0.28 |
2024-05-28 | -0.30 |
2024-05-24 | -0.30 |
2024-05-23 | -0.33 |
2024-05-22 | -0.34 |
2024-05-21 | -0.34 |
2024-05-20 | -0.33 |
2024-05-17 | -0.33 |
2024-05-16 | -0.36 |
2024-05-15 | -0.34 |